Related Experiment Videos
Congenital alopecia areata
Patsy Lenane1, Elena Pope, Bernice Krafchik
1Dermatology Department, The Hospital for Sick Children, Toronto, Ontario, Canada.
Journal of the American Academy of Dermatology
|February 5, 2005
Summary
Congenital alopecia areata, an autoimmune condition causing hair loss, can occur from birth. Clobetasol propionate showed the most promise for regrowth in infants with this condition.
Area of Science:
- Dermatology
- Pediatrics
Background:
- Alopecia areata is typically considered an acquired autoimmune condition causing nonscarring hair loss.
- Recent reports suggest its occurrence in the neonatal period, challenging its classification.
Observation:
- This study presents 4 cases of congenital alopecia areata diagnosed clinically in neonates.
- Patients experienced prolonged quiescent periods of hair loss, lasting 6 to 24 months.
Findings:
- Treatment involved minoxidil 2% and various topical steroids (hydrocortisone, betamethasone valerate, fluocinonide, clobetasol propionate).
- Clobetasol propionate 0.05% yielded the best results, achieving full hair regrowth in 50% of treated patients.
Implications:
- Alopecia areata can manifest congenitally, not just as an acquired disorder.
- Findings suggest congenital alopecia areata is a distinct entity requiring age-specific management strategies.